首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by br
admin
2011-02-03
62
问题
The European Commission said on Thursday it would toughen the regulation of medical devices as a result of concerns raised by breast implants produced by the defunct French company PIP, even as a scientific expert review it ordered concluded there was currently "insufficient evidence" that women using its products faced greater health risks than others.
John Dalli, health and consumer policy commissioner, pledged to examine surveillance and operation of the "notified bodies" that scrutinise medical devices across the EU in a current review of legislation, stressing: "The capacity to detect and minimise the risk of fraud must be increased."
His comments followed an official report released on Wednesday in France that called for national and EU-wide co-operation including random inspections and sampling of medical devices to prevent a repeat of the fraudulent use of substandard non-medical-grade silicone by PIP in implants sold to up to 400,000 women around the world.
Xavier Bertrand, France’s minister of health, called for enhanced action in France and across Europe in the wake of the study, which highlighted that Afssaps, the French medical regulator, did not inspect PIP from 2001 until a tip-off led officials to inspect and close down the company in 2010. Jean-Claude Mas, its founder, is under police investigation for manslaughter.
Mr. Bertrand has pledged to hire more health inspectors and undertake random checks on medical device companies following growing concerns over its regulatory system highlighted by the widespread use of PIP’s substandard breast implants.
A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK, Germany and the Czech Republic and has helped spark a fresh debate over tougher EU regulation of medical devices, which are subject to far less scrutiny than pharmaceuticals.
However, a review released on Thursday by the EU’s own Scientific Committee on Emerging and Newly Identified Health Risks concluded: "Breast implants can fail, regardless of manufacturer, and the probability of failure increases with time since implantation. In most cases, breast implant failure appears to be without identifiable health consequences for the patient with the exception of possible local complications."
It stressed that limited data meant that while there was no link between breast implants and cancer, there was a need for further work to understand the specific risks from the PIP products.
Mr. Bertrand has endorsed calls for a parliamentary inquiry in France as well as a report from the country’s social affairs inspectorate, mirroring similar moves that led to tough new requirements for the pharmaceutical industry introduced last year in the wake of concerns about Servier’s drug Mediator.
Medical device manufacturers have called for reforms to ensure that the national "notified bodies" which audit the quality of their products across Europe are of a consistently high standard, while cautioning that tough new regulatory requirements could harm the EU’s competitive advantage.
The French study showed that Afssaps had received multiple warnings over the relatively high failure rate of PIP implants compared with those made by other companies, even though the overall proportion remained modest.
From Financial Times, February 2, 2012
Which of the following countries have not all proposed to offer women free removal of PIP implants?
选项
A、France, Germany, UK
B、Germany, UK, Czech
C、US, Germany, Czech
D、Germany, France, Czech
答案
C
解析
本题为细节题。根据第六段“A French decision at the end of last year to offer all women free removal of PIP implants triggered similar proposals in the UK,Germany and the Czech Republic”可知提出这项建议的国家为France,UK,Germany and Czech。全文都在讲EU,没有提到US。故C错误。
转载请注明原文地址:https://kaotiyun.com/show/SM1K777K
0
专业英语四级
相关试题推荐
Agreatnumberofinstitutionsofhighereducation______sincethefoundingofPeople’sRepublicofChina.
NowElaineregrets______hardenoughwhileinthemiddleschool.
Myhopeis______hewillbecomeadoctorinthefuture.
Theytalkedforaboutanhourofthingsandpersons______theyrememberedintheschool.
The______capacityofthestadiumhasbeenenlarged.
Whydoadultsbelievethatalcoholicawarenessprogramsteachyoungpeoplenottoover-drink?Recently,readinganarticleabout
Thegreatestrecentsocialchangeshavebeen【C1】______thelivesofwomen.Duringthe20thcenturytherehasbeenaremarkable
StudentsarecalledinAmericanclasses
Theyear1400openedwithmorepeacefulnessthanusualinEngland.Onlyafewmonthsbefore,RichardII,weak,wicked,andtreac
TheNationalTrustinBritain,togetherwithsimilarvoluntaryorganizations,playsanincreasinglyimportantpartinthepreser
随机试题
课程方案(课程计划)
下列哪项表现子宫的"藏精气而不泻"
下列影响利润总额计算的项目有()。
诚实守信的基本要求有( )。
固定制造费用的耗费差异是()。
下列各项中,不属于企业收入的是()。
进行360度考评前要对考评者进行培训,培训的内容不包括()。
刑事强制工作的依据是《刑事诉讼法》。()
从20世纪90年代“人类基因工程”计划启动之日起,美国、日本和欧洲等展开了一场激烈的基因专利争夺战。因为谁拥有专利,就意味着谁就能在国际上获得_______基因产业的“王牌”,谁就能拥有今后基因开发的庞大市场。为此,美国等少数发达国家大量地将阶段性研究成果
[*]
最新回复
(
0
)